Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Cancel Anytime
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

South Africa's Caster Semenya crosses the line to win the gold in the women's 800-meter final during the Diamond League in Doha, Qatar, May 3, 2019.

The Associated Press

With the Summer Olympics fast approaching, the double gold-medalist Caster Semenya is facing a bizarre choice: she can compete in the 200-metre dash or the 5,000-metre long-distance event.

Those are the last options remaining to her today. The multiple world champion, who fought her way up from a small, impoverished South African village to reach global fame in the 800 metres, has been barred from her strongest track events – unless she takes chemicals to reduce her naturally elevated testosterone levels.

More than 11 years after the first gender-verification tests were imposed on her, Semenya has refused to surrender to the sport’s regulators. Her protracted legal battle against World Athletics, the international governing body, has now moved to the European Court of Human Rights, where she can pursue the rights issues that she sees at the heart of the dispute.

Story continues below advertisement

But with the growing likelihood that a ruling will not be issued before the Olympics begin in Tokyo in July, the 30-year-old runner is obliged to train for an event allowed by the new rules, even if it is far outside her middle-distance speciality.

“It just goes to show her bravery,” says Gregory Nott, one of the leaders of her legal team. “She’s an indomitable spirit. This is now her 11th year of having this hang over her head.”

Last year, Semenya was training for the 200-metre sprint. But earlier this month, South African sports officials suggested that she is more likely to compete in long-distance events.

“She has decided to go back to longer distances, above 3,000 metres,” Athletics South Africa president Aleck Skhosana told a parliamentary committee.

In an interview with The Globe and Mail, her lawyer would not confirm whether she has made a final decision. “She’s training,” Nott said. “There isn’t a day that goes by when she doesn’t run. It’s quite phenomenal.”

Semenya rarely grants interviews. But on her social media accounts last month, she said: “This fight is not just about me. It’s about taking a stand and fighting for dignity, equality and the human rights of women in sport. All we ask is to be able to run free, once and for all.”

World Athletics, for its part, has shown no sign of backing down, insisting its regulations are a “reasonable, necessary and proportionate” way to ensure fairness and equal rights for all female athletes.

Story continues below advertisement

Since winning her first world championship in 2009, athletics regulators and rival runners have demanded answers for Semenya’s extraordinary achievements. She was ordered to take medically unnecessary drugs to lower her testosterone, even though they made her constantly ill.

The athletics body introduced regulations for the naturally high testosterone levels in some women, but a court ruled in 2015 that there wasn’t enough evidence that female athletic performance was boosted by high testosterone.

By 2018, the International Association of Athletics Federations (now known as World Athletics) believed it had found enough evidence to impose the new testosterone limits – but only in the 400 metres, 800 metres and 1500 metres, which were precisely the distances in which Semenya specialized.

She challenged the rules in the Court of Arbitration for Sport, based in Switzerland, which rejected her challenge in a split 2-1 ruling – even though it expressed reservations about the new rules. Her appeal to the Swiss Federal Supreme Court was rejected last year.

Last month, Nott and his legal team – including the Canadian lawyers James Bunting and Carlos Sayao – filed their latest appeal at the European court, backed up by thousands of pages of documents.

They are also trying to raise about US$1-million to cover costs. Her fate has always been decided by courts in expensive European cities, and the new case in Strasbourg is no exception. Her supporters are raising funds by selling T-shirts with her favourite sayings, such as, “Doors might be closed but not locked.”

Story continues below advertisement

Despite her court losses, Semenya has won support around the world. The World Medical Association said the new regulations are flagrantly discriminatory and contrary to medical ethics, forcing athletes to take potentially harmful medication. Physicians are ethically obliged to refuse to administer such treatments, the association said.

Human Rights Watch, in a report in December, said the regulations are “arbitrary, invasive and degrading” and “not based on accepted science.” They are “implemented in coercive environments where women are forced to choose between their careers and their basic human rights,” it said.

A new international movement, #LetHerRun, led by doctors, scientists and former athletes, is campaigning for the right for Semenya and other athletes to compete in the Olympics without restrictions. They argue that the latest regulations are just a new variation of the sex testing and “nude parades” that have been imposed on female athletes for many decades. Women are being told that they are “not woman enough,” it says.

Nott, who first volunteered to work for Semenya when she was ordered to take gender verification tests after her world victory in 2009, says her legal case is ultimately about human dignity.

“The issue, for me, has become bigger and bigger, more understandable and more defensible,” he said.

“It’s about a person saying, ‘I’m Caster, this is who I am.’ Caster tests all of our ordinary thinking. She’s very proud of who she is. She is a woman and won’t be challenged on that. That’s strength in itself.”

Story continues below advertisement

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies